ArticleCancer immunology, immunotherapy : CII2026
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse.
Chi-Hsien Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.